Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series
Hematopoietic stem and progenitor cell (HSPC)-based gene therapy (GT) requires the collection of a large number of cells. While bone marrow (BM) is the most common source of HSPCs in pediatric donors, the collection of autologous peripheral blood stem cells (PBSCs) is an attractive alternative for G...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021-09-01
|
| シリーズ: | Molecular Therapy: Methods & Clinical Development |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2329050121000978 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
